Company
Mylan Pharms INC
Last checked: Nov 19, 2026Source: Drugs@FDA, ClinicalTrials.gov
NDAs and BLAs
19
15 still marketed
Novel approvals
3
Approvals since 2021
4
Originals and new uses
Phase 3 trials
0
Registered, any status
Trials by phase
All registered drug and biologic trials with this lead sponsor, any status. A public view of the pipeline.
Recent approvals
Originals and efficacy supplements, newest first.
- Vancomycin Hydrochloride new use Jun 26, 2024
- Hulio new use Jul 14, 2022
- Ermeza approved Apr 29, 2022
- Semglee approved Jul 28, 2021
- Hulio approved Jul 6, 2020
- Semglee approved Jun 11, 2020
- Vancomycin Hydrochloride approved Jul 10, 2018
- Fulphila approved Jun 4, 2018
- Symfi approved Priority reviewMar 22, 2018
- Cimduo approved Priority reviewFeb 28, 2018
Drugs in development (0)
Investigational drugs, not yet FDA-approved, in this company's active or recent Phase 2 and 3 trials. Phase 3 first.
No investigational drugs in Phase 2 or 3 trials under this sponsor name.
Recruiting Phase 3 trials
Largest first.
No recruiting Phase 3 trials under this sponsor name.
Marketed drugs (15)
Newest FDA action first.
- Hulio Adalimumab-Fkjp · 2020
- Semglee Insulin Glargine-Yfgn · 2021
- Ogivri Trastuzumab-Dkst · 2017
- Vancomycin Hydrochloride Vancomycin Hydrochloride · 2018
- Fulphila Pegfilgrastim-Jmdb · 2018
- Aloprim Allopurinol Sodium · 1996
- Semglee Insulin Glargine · 2020
- Symfi Efavirenz, Lamivudine, Tenofovir Disoproxil Fumarate · 2018
- Denavir Penciclovir · 1996
- Vusion Miconazole Nitrate, White Petrolatum, Zinc Oxide · 2006
- Cimduo Lamivudine, Tenofovir Disoproxil Fumarate · 2018
- Cystagon Cysteamine Bitartrate · 1994
- Lamivudine; Zidovudine Lamivudine, Zidovudine · 2015
- Zonalon Doxepin Hydrochloride · 1994
- Avita Tretinoin · 1997
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.